Legal Challenges Emerge for Eli Lilly's Retatrutide | Retatrutide News

Eli Lilly's Retatrutide is facing lawsuits affecting pharmacies and telemedicine. The legal issues highlight challenges in distributing GLP-1 agonists.
Market News · October 21, 2026